KALA BIO, Inc., a biopharmaceutical company, engages in the development of an on-premises artificial intelligence (AI) infrastructure platform for biotechnology research applications in the United States. The company develops Researgency, a...
Q1 2026
May 15, 2026
FY 2025
Apr 15, 2026
Q4 2025
Dec 31, 2025
Q3 2025
Nov 19, 2025
Q2 2025
Aug 8, 2025
